Preferred Label : casirivimab and imdevimab drug combination;
Obsolete resource : false;
MeSH synonym : casirivimab plus imdevimab; casirivimab, imdevimab drug combination; casirivimab and imdevimab; casirivimab-imdevimab;
MeSH Hyperonym : casirivimab-imdevimab;
MeSH hyponym : Ronpreve; REGN-COV2; REGN-COV; REGN10987 and REGN10933 mixture; Ronapreve;
Origin ID : C000711751;
UMLS CUI : C5433281;
ATC code(s)
- CISMeF manual mappings
- Currated CISMeF NLP mapping
- MeSH term(s) associated for indexing
- Pharmacological action(s)
- Record concept(s)
- See also (suggested by CISMeF)
- Semantic type(s)
- UMLS correspondences (same concept)
- Validated automatic mappings to BTNT
https://www.has-sante.fr/jcms/p_3344843/fr/ronapreve-casirivimab-/-imdevimab-prevention-de-la-covid-19
2022
false
false
false
France
COVID-19
casirivimab and imdevimab
treatment outcome
insurance, health, reimbursement
Post-Exposure prophylaxis
adult
adolescent
antiviral agents
evaluation of the transparency committee
COVID-19
casirivimab
casirivimab and imdevimab drug combination
imdevimab
---
https://www.has-sante.fr/jcms/p_3318295/fr/ronapreve-casirivimab-imdevimab
https://www.has-sante.fr/jcms/p_3318291/fr/decision-n-2022-0066/dc/sem-du-17-fevrier-2022-du-college-de-la-haute-autorite-de-sante-portant-autorisation-d-acces-precoce-de-la-specialite-ronapreve
2022
false
false
false
France
casirivimab and imdevimab
evaluation of the transparency committee
casirivimab
imdevimab
casirivimab and imdevimab drug combination
---
https://www.has-sante.fr/jcms/p_3281625/fr/ronapreve-casirivimab-imdevimab-covid-19
2022
false
false
false
France
French
COVID-19
Post-Exposure prophylaxis
evaluation of the transparency committee
adult
adolescent
aged
risk factors
immunocompromised host
drug combinations
casirivimab and imdevimab drug combination
casirivimab
imdevimab
injections, subcutaneous
infusions, intravenous
antiviral agents
casirivimab and imdevimab
---
Authorization of Casirivimab and Imdevimab with English-only Labels for Use in Relation
to the COVID-19 Pandemic
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2021/76129a-fra.php
2021
false
false
false
Canada
French
English
drug approval
canada
COVID-19
drug labeling
casirivimab
imdevimab
Casirivimab/Imdevimab
casirivimab and imdevimab drug combination
adult
adolescent
drug combinations
infusions, intravenous
drug information
casirivimab and imdevimab drug combination
coronavirus infections
antibodies, monoclonal, humanized
drug combinations
---
https://ansm.sante.fr/actualites/covid-19-extension-de-lutilisation-de-la-bitherapie-danticorps-monoclonaux-casirivimab-imdevimab-chez-certains-patients-hospitalises
2021
false
false
false
France
French
casirivimab and imdevimab drug combination
casirivimab and imdevimab
guidelines for drug use
summary of product characteristics
package leaflet
Product containing only casirivimab and imdevimab in parenteral dose form (medicinal
product form)
COVID-19
COVID-19
immunocompromised host
casirivimab and imdevimab drug combination
casirivimab
imdevimab
adult
aged
adolescent
Pre-Exposure Prophylaxis
Post-Exposure prophylaxis
inpatients
casirivimab and imdevimab drug combination
drug combinations
antibodies, monoclonal, humanized
coronavirus infections
---
https://www.has-sante.fr/jcms/p_3281544/fr/ronapreve-casirivimab-imdevimab-prophylaxie-pre-exposition-de-l-infection-a-sars-cov-2
https://has-sante.fr/jcms/p_3291779/fr/decision-n-2021-0259/dc/sem-du-7-octobre-2021-du-college-de-la-haute-autorite-de-sante-portant-autorisation-d-acces-precoce-de-la-specialite-ronapreve
2021
false
false
false
France
French
casirivimab and imdevimab drug combination
casirivimab and imdevimab
drug information
package leaflet
summary of product characteristics
guidelines for drug use
Product containing only casirivimab and imdevimab in parenteral dose form (medicinal
product form)
casirivimab and imdevimab drug combination
drug combinations
antibodies, monoclonal, humanized
casirivimab and imdevimab drug combination
treatment outcome
drug approval
Pre-Exposure Prophylaxis
COVID-19
injections, subcutaneous
infusions, intravenous
casirivimab
imdevimab
adult
adolescent
---
https://ansm.sante.fr/actualites/covid-19-lacces-aux-bitherapies-danticorps-monoclonaux-contre-la-covid-19-est-elargi
2021
false
false
false
France
French
drug information
drug combinations
antibodies, monoclonal, humanized
adult
Casirivimab/Imdevimab
Bamlanivimab
Etesevimab
guidelines for drug use
casirivimab
imdevimab
bamlanivimab
etesevimab
casirivimab and imdevimab drug combination
COVID-19
casirivimab and imdevimab drug combination
Product containing only casirivimab and imdevimab in parenteral dose form (medicinal
product form)
---
https://ansm.sante.fr/tableau-atu-rtu/casirivimab-imdevimab-120-mg-ml-solution-a-diluer-pour-perfusion-intraveineuse-ou-solution-pour-injection-sous-cutanee
2021
false
false
false
France
French
guidelines for drug use
antibodies, monoclonal, humanized
Casirivimab/Imdevimab
Casirivimab
infusions, intravenous
drug combinations
Imdevimab
summary of product characteristics
package leaflet
adult
aged
COVID-19
imdevimab
casirivimab and imdevimab drug combination
casirivimab
casirivimab and imdevimab drug combination
casirivimab and imdevimab
Pre-Exposure Prophylaxis
Product containing only casirivimab and imdevimab in parenteral dose form (medicinal
product form)
Post-Exposure prophylaxis
casirivimab and imdevimab drug combination
---
https://www.ansm.sante.fr/actualites/anticorps-monoclonaux-lansm-permet-lutilisation-en-acces-precoce-de-deux-bitherapies-contre-la-covid-19
2021
false
false
false
France
French
scientific and technical information
drug information
antibodies, monoclonal
adult
Casirivimab/Imdevimab
Casirivimab
Imdevimab
Anti-spike Protein SARS-CoV-2 Monoclonal Antibody
Bamlanivimab
Etesevimab
aged
spike glycoprotein, coronavirus
france
drug monitoring
risk
drug combinations
casirivimab and imdevimab drug combination
COVID-19
COVID-19
casirivimab
imdevimab
casirivimab and imdevimab
drug combinations
antibodies, monoclonal, humanized
Product containing only casirivimab and imdevimab in parenteral dose form (medicinal
product form)
casirivimab and imdevimab drug combination
---
https://ansm.sante.fr/actualites/anticorps-monoclonaux-contre-la-covid-19-autorisation-en-acces-precoce-de-la-bitherapie-ronapreve-casirivimab-imdevimab-en-prophylaxie
2021
false
false
false
France
French
COVID-19
drug information
casirivimab and imdevimab drug combination
casirivimab
drug combinations
antibodies, monoclonal, humanized
imdevimab
Casirivimab/Imdevimab
risk assessment
COVID-19 aggravated
COVID-19
risk
infusions, intravenous
injections, subcutaneous
adult
adolescent
Pre-Exposure Prophylaxis
casirivimab and imdevimab drug combination
casirivimab and imdevimab
casirivimab and imdevimab drug combination
drug combinations
Product containing only casirivimab and imdevimab in parenteral dose form (medicinal
product form)
---
